Carillon Tower Advisers’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
$17.6M Buy
+209,850
New +$17.6M 0.11% 268